A MHC class I & II deficient platform humanized with PBMCs

29 May 2022

In this white paper, The Jackson Laboratory describes how JAX NSG-MHC I/II KO mice readily engraft tumors and human PBMCs, have delayed GvHD, and deliver translationally-relevant results for various research applications.

Links

Tags